Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.920
-0.021 (-2.25%)
Nov 21, 2024, 4:00 PM EST - Market closed
Xilio Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 40 | 15 | 74 | 437 | - | - |
| Market Cap Growth | -40.37% | -79.46% | -83.14% | - | - | - |
| Enterprise Value | -11 | -30 | -45 | 581 | - | - |
| Last Close Price | 0.94 | 0.55 | 2.69 | 16.00 | - | - |
| PB Ratio | 1.97 | 0.41 | 0.70 | 2.36 | - | - |
| P/TBV Ratio | 1.65 | 0.41 | 0.70 | 2.36 | - | - |
| Debt / Equity Ratio | 0.40 | 0.34 | 0.19 | 0.11 | -4.14 | 0.49 |
| Quick Ratio | 1.61 | 2.80 | 5.70 | 15.50 | 0.87 | 9.38 |
| Current Ratio | 1.67 | 3.02 | 5.89 | 15.85 | 0.93 | 9.81 |
| Return on Equity (ROE) | -170.96% | -107.25% | -60.62% | -84.15% | -332.22% | - |
| Return on Assets (ROA) | -52.58% | -49.44% | -31.19% | -36.88% | -68.87% | - |
| Return on Capital (ROIC) | -83.23% | -56.49% | -33.58% | -42.11% | -92.02% | - |
| Earnings Yield | -151.82% | -504.62% | -119.66% | -17.33% | - | - |
| FCF Yield | -42.73% | -456.42% | -105.24% | -18.72% | - | - |
| Buyback Yield / Dilution | -61.00% | -0.38% | -388.59% | -970.34% | -27.97% | - |
| Total Shareholder Return | -61.00% | -0.38% | -388.59% | -970.34% | -27.97% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.